These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8387612)

  • 1. Skin fibroblast carnitine uptake in secondary carnitine deficiency disorders.
    Tein I; De Vivo DC; Ranucci D; DiMauro S
    J Inherit Metab Dis; 1993; 16(1):135-46. PubMed ID: 8387612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deficiency of medium-chain acyl coenzyme A dehydrogenase: studies in cultured skin fibroblasts and peripheral mononuclear leukocytes.
    Coates PM; Hale DE; Stanley CA; Corkey BE; Cortner JA
    Pediatr Res; 1985 Jul; 19(7):671-6. PubMed ID: 4022673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?
    Tein I; Sloane AE; Donner EJ; Lehotay DC; Millington DS; Kelley RI
    Pediatr Neurol; 1995 Jan; 12(1):21-30. PubMed ID: 7748356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels.
    Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L
    Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal handling of carnitine in secondary carnitine deficiency disorders.
    Stanley CA; Berry GT; Bennett MJ; Willi SM; Treem WR; Hale DE
    Pediatr Res; 1993 Jul; 34(1):89-97. PubMed ID: 8356025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.
    Boles RG; Buck EA; Blitzer MG; Platt MS; Cowan TM; Martin SK; Yoon H; Madsen JA; Reyes-Mugica M; Rinaldo P
    J Pediatr; 1998 Jun; 132(6):924-33. PubMed ID: 9627580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy.
    Tein I; De Vivo DC; Bierman F; Pulver P; De Meirleir LJ; Cvitanovic-Sojat L; Pagon RA; Bertini E; Dionisi-Vici C; Servidei S
    Pediatr Res; 1990 Sep; 28(3):247-55. PubMed ID: 2235122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder.
    Sewell AC; Bender SW; Wirth S; Münterfering H; Ijlist L; Wanders RJ
    Eur J Pediatr; 1994 Oct; 153(10):745-50. PubMed ID: 7813533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood.
    Rocchiccioli F; Wanders RJ; Aubourg P; Vianey-Liaud C; Ijlst L; Fabre M; Cartier N; Bougneres PF
    Pediatr Res; 1990 Dec; 28(6):657-62. PubMed ID: 2284166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.
    Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL
    Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deficiency of short-chain acyl-coenzyme A dehydrogenase in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness.
    Coates PM; Hale DE; Finocchiaro G; Tanaka K; Winter SC
    J Clin Invest; 1988 Jan; 81(1):171-5. PubMed ID: 3335634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia.
    Hale DE; Batshaw ML; Coates PM; Frerman FE; Goodman SI; Singh I; Stanley CA
    Pediatr Res; 1985 Jul; 19(7):666-71. PubMed ID: 4022672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?
    Holub M; Bodamer OA; Item C; Mühl A; Pollak A; Stöckler-Ipsiroglu S
    Acta Paediatr; 2005 Jan; 94(1):48-52. PubMed ID: 15858960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.
    Chegary M; Te Brinke H; Doolaard M; Ijlst L; Wijburg FA; Wanders RJ; Houten SM
    Mol Genet Metab; 2008 Apr; 93(4):403-10. PubMed ID: 18077198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.
    Shen JJ; Matern D; Millington DS; Hillman S; Feezor MD; Bennett MJ; Qumsiyeh M; Kahler SG; Chen YT; Van Hove JL
    J Inherit Metab Dis; 2000 Feb; 23(1):27-44. PubMed ID: 10682306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
    Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
    Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle.
    Tyni T; Pourfarzam M; Turnbull DM
    Pediatr Res; 2002 Jul; 52(1):64-70. PubMed ID: 12084849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.